Bcl-2 AS A MARKER FOR OVARIAN CANCER

    • Simple to use, noninvasive urine test
    • In initial clinical studies Bcl-2 has demonstrated higher sensitivity for detecting early stage of ovarian cancer when compared to CA-125
    • This immunoassay can be utilized for accurately predicting success of debulking surgery